Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience

INTRODUCTION: The latest guidelines of the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) to test Human Epidermal Growth Factor Receptor 2 (HER2) in breast cancer after being revised in 2008 underwent a second modification in October 2013. The modification includes...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Zsuzsanna, Noske, Aurelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608798/
https://www.ncbi.nlm.nih.gov/pubmed/26473483
http://dx.doi.org/10.1371/journal.pone.0140652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608798/
https://www.ncbi.nlm.nih.gov/pubmed/26473483
http://dx.doi.org/10.1371/journal.pone.0140652

Ejemplares similares